These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7597259)

  • 1. Fitting the two-stage clonal expansion model based on exact hazard to the ED01 data using SAS NLIN.
    Lensing SY; Kodell RL
    Risk Anal; 1995 Apr; 15(2):233-45. PubMed ID: 7597259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage and Weibull models for carcinogenesis applied to the ED01 discontinued dosing data.
    Kodell RL; Felton RP
    Environ Health Perspect; 1991 May; 92():155-66. PubMed ID: 1935845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling time-to-tumor data: analysis of the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):458-69. PubMed ID: 6642103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thresholds of carcinogenicity in the ED01 study.
    Waddell WJ
    Toxicol Sci; 2003 Mar; 72(1):158-63. PubMed ID: 12604845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-examination of the ED01 study. Overview.
    Fundam Appl Toxicol; 1981; 1(1):28-63. PubMed ID: 7184773
    [No Abstract]   [Full Text] [Related]  

  • 9. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-examination of the ED01 study - adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):67-80. PubMed ID: 7184775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study.
    Cohen SM; Ellwein LB
    Toxicol Appl Pharmacol; 1990 Jun; 104(1):79-93. PubMed ID: 2360210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-examination of the ED01 study--technical discussion of the statistical analysis for adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):81-7. PubMed ID: 7184777
    [No Abstract]   [Full Text] [Related]  

  • 13. Multistage prediction of cancer in serially dosed animals with application to the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):470-7. PubMed ID: 6642104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
    Ito N; Tatematsu M; Nakanishi K; Tsuda H
    Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
    [No Abstract]   [Full Text] [Related]  

  • 15. Multistage modeling of leukemia in benzene workers: a simple approach to fitting the 2-stage clonal expansion model.
    Richardson DB
    Am J Epidemiol; 2009 Jan; 169(1):78-85. PubMed ID: 18996834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exact analysis of the multistage model explaining dose-response concavity.
    Cox LA
    Risk Anal; 1995 Jun; 15(3):359-68. PubMed ID: 7604169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to the society of toxicology task force re-examination of the ED01 study.
    Kodell RL; Gaylor DW; Greenman DL; Littlefield NA; Farmer JH
    Fundam Appl Toxicol; 1983; 3(4):3a-12a. PubMed ID: 6688789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
    Lutz WK
    Toxicol Sci; 2003 Sep; 75(1):223; author reply 223-4. PubMed ID: 12923302
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.